An application of β-asarone in the preparation of a drug for promoting myelin regeneration.
LU604493B1Active Publication Date: 2026-07-01ZHEJIANG CHINESE MEDICAL UNIVERSITY
0 Cites 0 Cited by
Patent Information
- Application Number
- LU604493
- Authority / Receiving Office
- LU · LU
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-12-31
- Publication Date
- 2026-07-01
- Estimated Expiration
- 2045-12-31
Abstract
The application of β-asarone ether in the preparation of drugs for promoting myelin regeneration, for improving neurological dysfunction in organisms with myelin injury, inhibiting inflammatory demyelination in the central nervous system, and enhancing memory and cognitive function.
Need to check novelty before this filing date? Find Prior Art